Dr. Jeffrey Cernohous was born in 1971 and is a native of River Falls, Wisconsin. He received a B.S. in Chemistry from University of Wisconsin-River Falls in 1993 and a Ph.D. in Organic Chemistry from University of Minnesota in 1997. Dr. Cernohous spent 1997-2003 at 3M Company where he was focused on developing and commercializing new materials having a controlled molecular architecture.
In late 2003, he left 3M to found Interfacial Solutions out of his garage and was incubated by Phillips Plastics Corporation. Over a decade, Dr. Cernohous grew this business...Read more
Yunfeng Lu received his PhD in Chemical Engineering from the University of New Mexico. After his postdoc training at the Sandia National Laboratories, he joined Applied Materials as a senior processing engineer and Tulane University as an assistant professor. Currently, he is a professor of Chemical and Biomolecular Engineering, the University of California Los Angeles (UCLA). His research has been focused on material design and synthesis towards nanomedicine and energy applications (e.g., lithium-ion batteries, supercapacitors and fuel cells). In the nanomedicine area, he has developed a...Read more
This level 3 course will provide undergraduate students an introduction to Damage Mechanisms, Asset Integrity, and Reliability concepts which are not...
As the Vice President of Public Affairs at Novolex, Phil has become a nationally recognized expert in both plastic and paper packaging sustainability, as well as green marketing claims. Phil is an established researcher that advocates for waste reduction and lifecycle thinking in all products and business models and subscribes to the Sustainable Materials Management school of thought. He has published corporate...Read more
James M. Tour, a synthetic organic chemist, received his Bachelor of Science degree in chemistry from Syracuse University, his Ph.D. in synthetic organic and organometallic chemistry from Purdue University, and postdoctoral training in synthetic organic chemistry at the University of Wisconsin and Stanford University. After spending 11 years on the faculty of the Department of Chemistry and Biochemistry at the University of South Carolina, he joined the Center for Nanoscale Science and Technology at Rice University in 1999 where he is presently the T. T. and W. F. Chao Professor of...Read more
Dr. Julie Gerberding is Executive Vice President and Chief Patient Officer at Merck & Co., Inc., where she is responsible for a broad portfolio of patient engagement, communications, policy, philanthropic and other functions. She joined Merck in 2010 as president of vaccines and was instrumental in increasing access to the company’s vaccines to people around the world.
Previously, Dr. Gerberding was Director of the U.S. CDC, where she led the agency through SARS and over 40...Read more
This session will address how end-to-end supply chain strategies can assure that patients will receive timely and sustainable delivery of products. The spectrum from personalized medicines to millions of doses per year will be covered, for multiple modalities.
